Insider trades
Mark E. Saad, Director of Axsome Therapeutics AXSM, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $6.2M. The latest trade was on 06/08.
Mark E. Saad
Director
- Company
- Axsome Therapeutics AXSM
- First filing
- 23/03/06
- Trades
- 22 trades
- Buys / sales
- 0 / 4
- 12-month net buying
- −$6.2M
- Last trade
- 06/08
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AXSM | Open-market sale10b5-1 plan | 25/12/31 | 01/02 | 37,577 sh2 trades | $165.18avg. | $6,206,968.86 | −79.0% |
| Open-market sale10b5-1 plan | 25/09/05 | 25/09/05 | 9,127 sh | $125.07 | $1,141,513.89 | −47.7% | |
| Open-market sale10b5-1 plan | 24/09/11 | 24/09/11 | 11,016 sh | $91.31 | $1,005,870.96 | −52.4% |